Literature DB >> 31814574

Platelet parameters aid identification of adult-onset Still's disease from sepsis.

J-P Liu1, Y-M Wang, J Zhou.   

Abstract

BACKGROUND: Adult-onset Still's disease (AOSD) is a rare, chronic, and systemic inflammatory disorder. The current study aims to evaluate the ability of platelets (PLTs), plateletcrit (PCT), mean platelet volume (MPV), platelet distribution width (PDW), and PLT to PDW ratio (PPR) in a cohort of patients with AOSD or sepsis.
METHODS: Serum samples were obtained from 82 AOSD patients, 48 sepsis patients, and 76 matched healthy controls. Platelet parameters were measured by Sysmex XE 2100 analysers.
RESULTS: PPR and ferritin in AOSD patients were significantly higher than those in sepsis patients (22.18 ±; 11.12 vs. 13.80 ±; 8.97, p < 0.001; 3972.90 ±; 5134.04 μg/l vs. 518.92 ±; 382.50 μg/l, p = 0.001, respectively) and they were independent factors to differentiate AOSD from sepsis (OR: 5.86, 95%CI 1.59-21.60, p = 0.008; OR: 54.06, 95%CI 9.57-305.44, p < 0.001; respectively). Furthermore, PPR in AOSD and sepsis was significantly higher than that in matched controls. The area under the ROC curve of PPR, ferritin, and the combination were 0.733 (95%CI 0.646-0.820), 0.887 (95%CI 0.825-0.950), and 0.931 (95%CI 0.884-0.984), respectively.
CONCLUSION: PPR can be used as a useful marker to differentiate AOSD from sepsis and the combined identification value of PPR and ferritin is much higher than that of any single factor.

Entities:  

Year:  2019        PMID: 31814574

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  2 in total

1.  Role of mean platelet volume in differential diagnosis of adult-onset Still's disease and sepsis.

Authors:  John L Frater; Cara Lunn Shirai
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-05-13       Impact factor: 1.712

2.  The role of platelet to mean platelet volume ratio in the identification of adult-onset still's disease from sepsis.

Authors:  Suohua Ge; Yongbin Ma; Mengxiao Xie; Tengfei Qiao; Jun Zhou
Journal:  Clinics (Sao Paulo)       Date:  2021-04-16       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.